Wednesday, September 30, 2015

Safe treatment of pain and inflammation

ATE.V could be a giant in the making

Every health care stock on my list the past 18 months has knocked it out of the park.

I don't want you to buy or even look at ATE.V unless you know what it's all about and what it is capable of in the near future. When news breaks and phase 2 kicks in then the volatility will attract a lot of flippers and the quiet bullboard could be a mad house.

 "Antibe Therapeutics is pursuing a major advance in the safe treatment of pain and inflammation."
This is the time to make a decision to buy or move along, when there are no screaming posters talking about the moon or promising what they know can never be delivered from any company. I personally have made my decision based on my investigation into the facts and events that I believe are about to unfold. My time horizon on investing has dramatically changed over the years. I don't chase momo plays or get caught in all the noise. I quietly accumulate while others are taking small profits or running from a story that may or may not have been over sold.

 "Now in human clinical trials, Antibe's first drug targets mild-to-moderate pain and inflammation arising from a wide range of medical conditions."
Stay away if you cant live with the volatility and hype that may show up in the coming days. Stay away if you cant invest in a stock without watching it every second, stay away if you want to retire off of one stock in a blazing leap of faith based on others trying to pressure your decisions. The stock bullboards can be your best friend and your worst enemy in the same minute.

I don't post very often any more but to those I know who did invest in ATE.V I just want to say I am still here, I did not move on. I think the best is yet to come and I didn't buy for 200% or even 500% return, I see more ahead and I don't think we will have to wait that long either. I don't want to make a price prediction, everyone has to set their own target or move onto something they think is a better fit.

I do not not offer advice or analysis, and further urge you to consult your own independent tax, business, financial and investment advisor. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.